The Global Tuberculosis Therapeutics Market Size is anticipated to exceed USD 6.49 billion by 2033, growing at a CAGR of 5.75% from 2023 to 2033. Drugs and treatments designed to fight tuberculosis (TB) are developed, produced, and distributed as part of the tuberculosis therapeutics market. This market focuses on treating both latent and active tuberculosis, with treatments intended to treat both drug-resistant and drug-susceptible strains of the illness